When did the U.S. FDA conduct the inspection at Dabur India's manufacturing facility that resulted in findings about data integrity lapses?

Answer: January 2026

The FDA inspection of Dabur India's plant in Dadra and Nagar Haveli took place in January 2026. The inspection findings, issued subsequently in May 2026, highlighted concerns regarding data integrity, maintenance issues, and potential microbiological contamination risks.